A typical example of CAR T therapies is the CAR T cocktail immunotherapy composed of successive infusions of CART cells targeting epidermal growth factor receptor (EGFR) and CD133, which specifically target CSCs in cholangiocarcinoma (NCT01869166 and NCT02541370).418. Here, EGFR is linked to cholangiocarcinoma.